 | Up a level |
Shelan, Mohamed; Anschuetz, Lukas; Schubert, Adrian D; Bojaxhiu, Beat; Dal Pra, Alan; Behrensmeier, Frank; Aebersold, Daniel; Giger, Roland; Eliçin, Olgun (2017). T1-2 glottic cancer treated with radiotherapy and/or surgery. Strahlentherapie und Onkologie, 193(12), pp. 995-1004. Springer-Medizin-Verlag 10.1007/s00066-017-1139-4
Ghadjar, Pirus; Bojaxhiu, Beat; Simcock, Mathew; Terribilini, Dario; Isaak, Bernhard; Gut, Philipp; Wolfensberger, Patrick; Brömme, Jens O; Geretschläger, Andreas; Behrensmeier, Frank; Pica, Alessia; Aebersold, Daniel M (2012). High Dose-Rate Versus Low Dose-Rate Brachytherapy for Lip Cancer. International journal of radiation oncology, biology, physics, 83(4), pp. 1205-12. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2011.09.038
Ghadjar, Pirus; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Thalmann, George N; Aebersold, Daniel M (2011). Urethral toxicity vs. cancer control-Lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Brachytherapy, 10(4), pp. 286-94. New York, N.Y.: Elsevier
Ghadjar, Pirus; Gwerder, Nicole; Madlung, Axel; Behrensmeier, Frank; Thalmann, George N; Mini, Roberto; Aebersold, Daniel M (2009). Use of gold markers for setup in image-guided fractionated high-dose-rate brachytherapy as a monotherapy for prostate cancer. Strahlentherapie und Onkologie, 185(11), pp. 731-5. Heidelberg: Urban and Vogel 10.1007/s00066-009-2007-7
Ghadjar, Pirus; Matzinger, Oscar; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Rentsch, Cyrill A; Thalmann, George N; Aebersold, Daniel M (2009). Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer. Radiotherapy and oncology, 91(2), pp. 237-42. Amsterdam: Elsevier 10.1016/j.radonc.2008.12.007
Ghadjar, Pirus; Keller, Tamara; Rentsch, Cyrill A; Isaak, Bernhard; Behrensmeier, Frank; Stroux, Andrea; Thalmann, George N; Aebersold, Daniel M (2009). Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy, 8(1), pp. 45-51. New York, N.Y.: Elsevier 10.1016/j.brachy.2008.09.004
Ghadjar, Pirus; Vock, Jacqueline; Vetterli, Daniel; Manser, Peter; Bigler, Roland; Tille, Jan; Madlung, Axel; Behrensmeier, Frank; Mini, Roberto; Aebersold, Daniel M (2008). Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking. Radiation oncology, 3, p. 35. London: BioMed Central 10.1186/1748-717X-3-35
Vetterli, Daniel; Thalmann, Sandrine; Behrensmeier, Frank; Kemmerling, Ludger; Born, Ernst J; Mini, Roberto; Greiner, Richard H; Aebersold, Daniel M (2006). Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode. Radiotherapy and oncology, 79(1), pp. 101-8. Amsterdam: Elsevier 10.1016/j.radonc.2006.03.005
